MiniMed Group Income Statement

Financials in millions USD. Fiscal year is May - April.

Millions USD. Fiscal year is May - Apr.

Fiscal Quarter	Q4 2026	Q3 2026	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025
Period Ending	Apr '26 Apr 24, 2026	Jan '26 Jan 23, 2026	Oct '25 Oct 24, 2025	Jul '25 Jul 24, 2025	Apr '25 Apr 25, 2025	Jan '25 Jan 24, 2025	Oct '24 Oct 25, 2024	Jul '24 Jul 25, 2024
Net sales	837
Net sales Growth	15.61%
Cost of products sold	357
Cost of products sold Growth	12.26%
Gross profit	480
Gross profit Growth	18.52%
Operating expenses
Research and development expense	99
Research and development expense Growth	-7.48%
Selling, general, and administrative expense	299
Selling, general, and administrative expense Growth	8.33%
Certain litigation charges, net	7
Certain litigation charges, net Growth	-95.76%
Other Operating Expense, Net	168
Other Operating Expense, Net Growth	4100.00%
Operating loss	-93
Other Non-Operating Expense, Net	-1
Loss before income taxes	-92
Income tax provision	93
Income tax provision Growth	342.86%
Net loss	-185
Net income attributable to noncontrolling interests	0
Net loss attributable to the Company	-185
Loss per share
Basic and diluted loss per share	-0.68
Weighted-average shares outstanding
Basic	268.1
Basic Growth	6.05%

SEC Filings: 10-K · 10-Q